Oncolytics Biotech, Inc. (ONCY)
0.8228
+0.02
(+2.84%)
USD |
NASDAQ |
Jun 11, 16:00
0.8196
0.00 (0.00%)
After-Hours: 18:10
Oncolytics Biotech Max Drawdown (5Y) : 92.83% for May 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| May 31, 2026 | 92.83% |
| April 30, 2026 | 92.83% |
| March 31, 2026 | 92.83% |
| February 28, 2026 | 92.83% |
| January 31, 2026 | 92.83% |
| December 31, 2025 | 92.83% |
| November 30, 2025 | 92.83% |
| October 31, 2025 | 92.83% |
| September 30, 2025 | 92.83% |
| August 31, 2025 | 92.83% |
| July 31, 2025 | 92.83% |
| June 30, 2025 | 92.83% |
| May 31, 2025 | 92.67% |
| April 30, 2025 | 89.44% |
| March 31, 2025 | 89.44% |
| February 28, 2025 | 89.44% |
| January 31, 2025 | 89.44% |
| December 31, 2024 | 89.44% |
| November 30, 2024 | 90.02% |
| October 31, 2024 | 91.93% |
| September 30, 2024 | 96.10% |
| August 31, 2024 | 96.21% |
| July 31, 2024 | 96.21% |
| June 30, 2024 | 96.21% |
| May 31, 2024 | 96.21% |
| Date | Value |
|---|---|
| April 30, 2024 | 96.21% |
| March 31, 2024 | 96.21% |
| February 29, 2024 | 96.21% |
| January 31, 2024 | 96.21% |
| December 31, 2023 | 96.21% |
| November 30, 2023 | 96.21% |
| October 31, 2023 | 96.21% |
| September 30, 2023 | 96.21% |
| August 31, 2023 | 96.21% |
| July 31, 2023 | 96.21% |
| June 30, 2023 | 96.21% |
| May 31, 2023 | 96.21% |
| April 30, 2023 | 96.21% |
| March 31, 2023 | 96.21% |
| February 28, 2023 | 96.21% |
| January 31, 2023 | 96.21% |
| December 31, 2022 | 96.21% |
| November 30, 2022 | 96.21% |
| October 31, 2022 | 96.21% |
| September 30, 2022 | 96.21% |
| August 31, 2022 | 96.21% |
| July 31, 2022 | 96.21% |
| June 30, 2022 | 96.21% |
| May 31, 2022 | 96.21% |
| April 30, 2022 | 96.21% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Replimune Group, Inc. | 95.70% |
| Arrowhead Pharmaceuticals, Inc. | 88.96% |
| Sangamo Therapeutics, Inc. | 99.17% |
| Sarepta Therapeutics, Inc. | 93.33% |
| Anixa Biosciences, Inc. | 70.17% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -34.24 |
| Beta (5Y) | 1.069 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 88.61% |
| Historical Sharpe Ratio (5Y) | -0.2583 |
| Historical Sortino (5Y) | -0.7935 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 25.44% |